Churg-Strauss syndrome: a case report.

Area of Science:

• Medicine
• Pulmonology
• Rheumatology

Background:

• Churg Strauss Syndrome (CSS), also known as Eosinophilic Granulomatosis with Polyangiitis (EGPA), is a rare systemic vasculitis characterized by asthma, hypereosinophilia, and multi-systemic involvement.
• CSS often presents with respiratory symptoms, peripheral neuropathy, and skin manifestations, posing diagnostic challenges.

Observation:

• A 50-year-old female with a history of asthma and peripheral neuropathy presented with acute dyspnea, productive cough, arthralgia, and fever.
• Physical examination revealed tachypnea, wheezing, crackles, tachycardia, and widespread skin lesions including nodules, urticaria, and necrotic bullae.
• Radiological and laboratory findings included consolidation on chest X-ray, obstructive pattern on spirometry, elevated inflammatory markers (CRP, WBC, eosinophils), and elevated IgE levels.

Findings:

• The patient was diagnosed with Churg Strauss Syndrome based on clinical presentation and investigations.
• Initial treatment with prednisone resulted in rapid normalization of temperature and improvement in dyspnea within four days.
• Significant regression of skin lesions was observed after one month of therapy, with complete remission of signs and symptoms after 18 months of continuous corticosteroid treatment.

Implications:

• This case highlights the importance of considering CSS in patients with refractory asthma, eosinophilia, and multi-systemic involvement.
• Prompt diagnosis and aggressive immunosuppressive therapy, particularly with corticosteroids, are crucial for achieving favorable outcomes and preventing long-term complications in CSS.
• Long-term corticosteroid therapy may be necessary for sustained remission in Churg Strauss Syndrome.